United States Diabetes Market will be USD 26.28 Billion by 2025

Diabetes Mellitus mostly called Diabetes is metabolic diseases which cause high blood sugar. With diabetes, body either doesn’t make enough insulin or can’t effectively use insulin which prior it make. Diabetes is one of the most costly chronic disease in the United States. Despite its prevalence, millions of people don’t know they have such disease. In the US, people with diabetes have health care cost more than that of the people who don’t have such disease.

In the United States, approximately 67.3% of the cost for diabetes care is provided by government insurance say Medicaid, Medicare, and the military and at the same time rest is paid for by private insurance 30.7% or by the uninsured 2% according to ADA. In the recent years, US government spends US$150 million in diabetes research at National Institute of Health most commonly called NIH.

The driving force towards this market growth are Rising Diabetes Mellitus in an Aging Population, Rising prevalence of diabetes in various age groups, Rising Government Funding for Diabetes Management, Benefits of Insulin Pump over Multiple Daily Injection, Lifestyle-Compatible Treatment Options and Technological Advancement in Insulin Pump.

However, there are few challenges also associated with diabetes industry such as Technological advancements in insulin infusion devices, Blood Glucose Meter Accuracy Problem, Low Compliance of Glucose Monitoring & Inadequate Reimbursement for SMBG Supplies, Safety Issues in Insulin Pump Devices, and Difficulties Associated with the Pump Adherence.

Request a Free Sample Copy of the Report: https://www.renub.com/request-sample-page.php?gturl=united-states-diabetes-market-p.php

Segment Market breakup based on Devices from 4 viewpoints

• Continuous Glucose Monitoring (CGM)
• Self Monitoring Blood Glucose (SMBG)
• Insulin Pen
• Insulin Pump

1. Continuous Glucose Monitoring (CGM) – Sub-Segment Market breakup from 4 viewpoints

1. Glucose Sensor
2. CGM Transmitter
3. CGM User
4. CGM Reimbursement

2. Self-monitoring of blood glucose (SMBG) – Sub-Segment Market breakup from 5 viewpoints

1. Test Strips Market and Forecast
2. Lancet Market and Forecast
3. Meter Market and Forecast
4. Blood Glucose (SMBG) Users
5. Blood Glucose Devices Reimbursement

3. Insulin Pen Market – Sub-Segment Market breakup from 5 viewpoints

1. Disposable Insulin Pen
2. Reusable Insulin Pen
3. Smart Insulin Pen
4. Insulin Pen Needle
5. Reimbursement Policies

4. Insulin Pump Market

1. Insulin Pump Market
2. USA (By States) – Diabetes Supplies
3. Reimbursement Policies by State-Sponsored Health Program

All the 11 Companies Studied in the Report have been Studied from 3 Viewpoints

• Company Overview
• Recent Developments
• Financial Insight

Company Analysis

1. B. Braun Melsungen AG
2. Eli Lilly and Company
3. Artsana S.p.A
4. BD
5. Novo Nordisk A/S
6. Owen Mumford Ltd
7. Ypsomed AG
8. Medtronic
9. Insulet Corporation
10. LifeScan Inc.
11. Abbott Laboratories